Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kalhs

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|June 12, 2008
Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCTKatarina Ludajic, Yesilda Balavarca, Heike Bickeböller, et al.
NPJ Vaccines|July 31, 2020
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
NPJ Vaccines|September 14, 2020
Erratum: Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
The Journal of Investigative Dermatology|November 19, 2014
Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host diseaseMarie-Charlotte Brüggen, Peter Petzelbauer, Hildegard Greinix, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
British Journal of Haematology|June 13, 2002
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation RegistryHildegard T Greinix, David Nachbaur, Otto Krieger, et al.
Transfusion|October 1, 2010
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient programNina Worel, Konrad Rosskopf, Peter Neumeister, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicityNina Worel, Axel Schulenburg, Margit Mitterbauer, et al.
Oncology|August 1, 2015
Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center ExperienceWolfgang Lamm, Philipp Wohlfarth, Marija Bojic, et al.
Transfusion|July 19, 2003
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantationNina Worel, Peter Kalhs, Felix Keil, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|June 12, 2008
Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCTKatarina Ludajic, Yesilda Balavarca, Heike Bickeböller, et al.
NPJ Vaccines|July 31, 2020
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
NPJ Vaccines|September 14, 2020
Erratum: Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
The Journal of Investigative Dermatology|November 19, 2014
Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host diseaseMarie-Charlotte Brüggen, Peter Petzelbauer, Hildegard Greinix, et al.
Wiener Klinische Wochenschrift|January 1, 2009
Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformPeter Valent, Thomas Lion, Dominik Wolf, et al.
British Journal of Haematology|June 13, 2002
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation RegistryHildegard T Greinix, David Nachbaur, Otto Krieger, et al.
Transfusion|October 1, 2010
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient programNina Worel, Konrad Rosskopf, Peter Neumeister, et al.
Wiener Klinische Wochenschrift|February 21, 2006
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicityNina Worel, Axel Schulenburg, Margit Mitterbauer, et al.
Oncology|August 1, 2015
Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center ExperienceWolfgang Lamm, Philipp Wohlfarth, Marija Bojic, et al.
Transfusion|July 19, 2003
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantationNina Worel, Peter Kalhs, Felix Keil, et al.
Pageof 6